[(1S,2S,4R)-2-ethyl-2-(hydroxymethyl)-7-azabicyclo[2.2.1]heptan-7-yl]-[3-(4-hydroxyphenyl)-1H-pyrazol-5-yl]methanone

C19H23N3O3 — CID 165425875

IUPAC[(1S,2S,4R)-2-ethyl-2-(hydroxymethyl)-7-azabicyclo[2.2.1]heptan-7-yl]-[3-(4-hydroxyphenyl)-1H-pyrazol-5-yl]methanone
SMILESCC[C@]1(CO)C[C@H]2CC[C@@H]1N2C(=O)c1cc(-c2ccc(O)cc2)n[nH]1
InChIInChI=1S/C19H23N3O3/c1-2-19(11-23)10-13-5-8-17(19)22(13)18(25)16-9-15(20-21-16)12-3-6-14(24)7-4-12/h3-4,6-7,9,13,17,23-24H,2,5,8,10-11H2,1H3,(H,20,21)/t13-,17+,19-/m1/s1
InChIKeyINXPNZZNRXSZFM-XVGQJIODSA-N
MW341.41 g/mol
LogP2.55
Rot. Bonds4

About [(1S,2S,4R)-2-ethyl-2-(hydroxymethyl)-7-azabicyclo[2.2.1]heptan-7-yl]-[3-(4-hydroxyphenyl)-1H-pyrazol-5-yl]methanone

[(1S,2S,4R)-2-ethyl-2-(hydroxymethyl)-7-azabicyclo[2.2.1]heptan-7-yl]-[3-(4-hydroxyphenyl)-1H-pyrazol-5-yl]methanone (PubChem CID 165425875) has the molecular formula C19H23N3O3 and a molecular weight of 341.41 g/mol. Its IUPAC name is [(1S,2S,4R)-2-ethyl-2-(hydroxymethyl)-7-azabicyclo[2.2.1]heptan-7-yl]-[3-(4-hydroxyphenyl)-1H-pyrazol-5-yl]methanone.

Molecular Properties

Compound Name[(1S,2S,4R)-2-ethyl-2-(hydroxymethyl)-7-azabicyclo[2.2.1]heptan-7-yl]-[3-(4-hydroxyphenyl)-1H-pyrazol-5-yl]methanone
PubChem CID165425875
Molecular FormulaC19H23N3O3
Molecular Weight341.41 g/mol
Exact Mass341.17
IUPAC Name[(1S,2S,4R)-2-ethyl-2-(hydroxymethyl)-7-azabicyclo[2.2.1]heptan-7-yl]-[3-(4-hydroxyphenyl)-1H-pyrazol-5-yl]methanone
SMILESCC[C@]1(CO)C[C@H]2CC[C@@H]1N2C(=O)c1cc(-c2ccc(O)cc2)n[nH]1
InChIInChI=1S/C19H23N3O3/c1-2-19(11-23)10-13-5-8-17(19)22(13)18(25)16-9-15(20-21-16)12-3-6-14(24)7-4-12/h3-4,6-7,9,13,17,23-24H,2,5,8,10-11H2,1H3,(H,20,21)/t13-,17+,19-/m1/s1
InChIKeyINXPNZZNRXSZFM-XVGQJIODSA-N
XLogP2.55
TPSA89.45 Ų
H-Bond Donors3
H-Bond Acceptors4
Rotatable Bonds4
Heavy Atoms25
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500341.41
LogP ≤ 52.55
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 104

Analyze [(1S,2S,4R)-2-ethyl-2-(hydroxymethyl)-7-azabicyclo[2.2.1]heptan-7-yl]-[3-(4-hydroxyphenyl)-1H-pyrazol-5-yl]methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [(1S,2S,4R)-2-ethyl-2-(hydroxymethyl)-7-azabicyclo[2.2.1]heptan-7-yl]-[3-(4-hydroxyphenyl)-1H-pyrazol-5-yl]methanone?
The IUPAC name of [(1S,2S,4R)-2-ethyl-2-(hydroxymethyl)-7-azabicyclo[2.2.1]heptan-7-yl]-[3-(4-hydroxyphenyl)-1H-pyrazol-5-yl]methanone (CID 165425875) is [(1S,2S,4R)-2-ethyl-2-(hydroxymethyl)-7-azabicyclo[2.2.1]heptan-7-yl]-[3-(4-hydroxyphenyl)-1H-pyrazol-5-yl]methanone.
What is the SMILES notation for [(1S,2S,4R)-2-ethyl-2-(hydroxymethyl)-7-azabicyclo[2.2.1]heptan-7-yl]-[3-(4-hydroxyphenyl)-1H-pyrazol-5-yl]methanone?
The canonical SMILES for [(1S,2S,4R)-2-ethyl-2-(hydroxymethyl)-7-azabicyclo[2.2.1]heptan-7-yl]-[3-(4-hydroxyphenyl)-1H-pyrazol-5-yl]methanone is CC[C@]1(CO)C[C@H]2CC[C@@H]1N2C(=O)c1cc(-c2ccc(O)cc2)n[nH]1.
What is the InChIKey of [(1S,2S,4R)-2-ethyl-2-(hydroxymethyl)-7-azabicyclo[2.2.1]heptan-7-yl]-[3-(4-hydroxyphenyl)-1H-pyrazol-5-yl]methanone?
The InChIKey is INXPNZZNRXSZFM-XVGQJIODSA-N. The full InChI is InChI=1S/C19H23N3O3/c1-2-19(11-23)10-13-5-8-17(19)22(13)18(25)16-9-15(20-21-16)12-3-6-14(24)7-4-12/h3-4,6-7,9,13,17,23-24H,2,5,8,10-11H2,1H3,(H,20,21)/t13-,17+,19-/m1/s1.
What are the key properties of [(1S,2S,4R)-2-ethyl-2-(hydroxymethyl)-7-azabicyclo[2.2.1]heptan-7-yl]-[3-(4-hydroxyphenyl)-1H-pyrazol-5-yl]methanone?
[(1S,2S,4R)-2-ethyl-2-(hydroxymethyl)-7-azabicyclo[2.2.1]heptan-7-yl]-[3-(4-hydroxyphenyl)-1H-pyrazol-5-yl]methanone has a molecular weight of 341.41 g/mol, XLogP of 2.55, 4 rotatable bonds, 3 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for [(1S,2S,4R)-2-ethyl-2-(hydroxymethyl)-7-azabicyclo[2.2.1]heptan-7-yl]-[3-(4-hydroxyphenyl)-1H-pyrazol-5-yl]methanone is sourced from PubChem (CID 165425875), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).